Biotech Values

[xray72]

I would disagree. I know of atleast one drug in PhIII which actually cleared a very significant portion of patients from their metastatic cancer (many patients had only a few months left of median survial before treatment). The exaxt mechanism of this drug is not even fully understood by their inventors, though. Will see if this will be a longlasting effect but there is certainly some potential.
Another reason why I would not want to be long on companies like Dendreon which show only very incremental advantages.